CJC-1295 (No DAC) + Ipamorelin 1:1 Research Blend

This product is a precise 1:1 blend by mass of CJC-1295 (without DAC) and Ipamorelin. Formulated for controlled research environments. Designed for advanced peptide research, this co-formulation supports studies exploring GHRH-receptor and ghrelin (GHS-R1a)–receptor signaling pathways when evaluated together in validated model systems.

Researchers comparing CJC-1295 vs Ipamorelin often seek to understand how GHRH analogs and ghrelin-receptor agonists interact within growth hormone regulatory networks. This dual-peptide blend provides a standardized, research-grade tool to investigate synergistic signaling, receptor crosstalk, and downstream effects in non-clinical assays.

Each batch is supplied as a lyophilized research material. Moreover, with documented identity and purity specifications, supporting reproducible experimental design and robust analytical workflows. Therefore, Ideal for institutional laboratories and qualified professionals focused on endocrine signaling, receptor pharmacology, and peptide co-formulation studies.

Research Focus (Non-Clinical)

Comparative and combined evaluation of a GHRH analog and GHS agonist in in vitro or ex vivo models. Also, this Supports assay development, including chromatographic separation of co-formulated peptides. Enables stability characterization of a two-analyte lyophilized blend under controlled laboratory storage conditions. Facilitates method documentation for HPLC and LC-MS identity and purity assessments.

 Compound Profile of Cjc 1295 vs Ipamorelin

– Purity: ≥99% (HPLC)
– Molecular Weight: C152H252N44O42 (3,367.9 g/mol) · C38H49N9O5 (711.8 g/mol)
– Form: Lyophilized Powder
– Storage: 36–46°F (Refrigerated)